XML 62 R44.htm IDEA: XBRL DOCUMENT v3.20.4
Other assets impairments, restructuring and other items (Tables)
12 Months Ended
Dec. 31, 2020
Schedule of Other Assets Impairments, Restructuring and Other Items
    
Year ended December 31,
 
    
2020
    
2019
    
2018
 
    
(U.S. $ in millions)
 
Impairment of long-lived tangible assets
(1)
   $ 416      $ 139      $ 500  
Contingent consideration (see note 2)
     (81      59        57  
Restructuring
     120        199        488  
Other
     24       
26
       (58
    
 
 
    
 
 
    
 
 
 
Total
   $ 479      $ 423      $ 987  
    
 
 
    
 
 
    
 
 
 
 
(1)
Including impairments related to exit and disposal activities.
Summary of Restructuring Plan Including Costs Related to Exit and Disposal
The following tables provide the components of costs associated with Teva’s restructuring plan, including other costs associated with Teva’s restructuring plan and recorded under different items:
 
    
Year ended December 31,
 
    
2020
    
2019
    
2018
 
    
(U.S. $ in millions)
 
Restructuring
                          
Employee termination
   $ 71      $ 159      $ 410  
Other
     49        40        78  
    
 
 
    
 
 
    
 
 
 
Total
   $ 120      $ 199      $ 488  
    
 
 
    
 
 
    
 
 
 
Summary of Restructuring Accruals
The following table provides the components of and changes in the Company’s restructuring accruals:
 
    
Employee
termination costs
    
Other
    
Total
 
    
(U.S. $ in millions )
 
Balance as of January 1, 2019
   $ (204    $ (29    $ (233
Provision
     (159      (40      (199
Utilization and other*
     155        62        217  
    
 
 
    
 
 
    
 
 
 
Balance as of December 31, 2019
   $ (208    $ (7    $ (215
Provision
 
 
(71
)
 
 
(49
)
 
 
 (120
)
Utilization and other
*
 
 
164
 
 
 
49
 
 
 
213
 
Balance as of December 31, 2020
 
$
(115
)
 
$
(7
)
 
$
(122
)
    
 
 
    
 
 
    
 
 
 
 
*
Includes adjustments for foreign currency translation.